In order to better understand the biological characteristics of BBD, a few authors have focused on estrogen receptor (ER) 7, 8, progesterone receptor (PR) 9, and Ki67 7, 10, 11 as biomarkers expressed in benign lesions that are not in proximity to concomitant breast cancer. This evidence concerns the gene PGR and breast cancer.